Muscle stem cell therapy method for treating muscular atrophy

Through a systematic method of isolating, culturing and activating muscle stem cells, the problem of cell isolation and activation in muscle atrophy treatment is solved, and the muscle function and quality of life are significantly improved, and the effectiveness of muscle stem cell therapy is achieved.

CN119015316APending Publication Date: 2024-11-26SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI +1
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410948777.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The prior art cannot effectively isolate, cultivate, transplant and activate muscle stem cells, resulting in poor results in muscle atrophy treatment and cannot fundamentally solve muscle tissue damage and loss of function.

Method used

By isolating muscle stem cells from the muscle tissue of a patient or healthy donor, sorted using enzyme digestion and flow cytometry, cultured in culture medium of growth factors and nutrients, using multi-point injection and electrical stimulation, medication or Genetically engineered activate cells, combined with rehabilitation training and regular monitoring, simulate the in vivo microenvironment for three-dimensional culture.

Benefits of technology

It significantly improves the purity and transplant success rate of muscle stem cells, promotes cell differentiation and proliferation, improves muscle function and quality of life, avoids immune rejection, and systematic steps improves the therapeutic effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015316A_ABST
    Figure CN119015316A_ABST
Patent Text Reader

Abstract

The present invention discloses a muscle stem cell therapy method for treating muscle atrophy, and provides a muscle stem cell therapy for treating muscle atrophy by isolating muscle stem cells from muscle tissues of a patient or a healthy donor, avoiding immunological rejection, and providing a variety of cell sources. High-purity cells are obtained through enzyme digestion and flow cytometry sorting technologies, the culture and transplantation success rate is increased, the cells are cultured in a culture medium containing growth factors and nutrient substances and regularly replaced to maintain activity and multiplication capacity, uniform distribution of the cells in damaged muscles is ensured through a multi-point injection technology, the treatment effect is enhanced, and the treatment effect is improved. Postoperative rehabilitation training is combined with regular iconography and biochemical monitoring, and the muscle function is systematically recovered. The three-dimensional culture system simulates an in-vivo microenvironment, the physiological function and survival rate of cells are improved, and the method remarkably improves the muscle function and life quality of the patient with muscle atrophy through systematic steps and an innovative technology.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of muscle stem cells, and more particularly to a muscle stem cell therapy method for treating muscle atrophy. Background Art

[0002] Muscular atrophy is a common and serious muscle disease, usually caused by aging, nerve damage, lack of exercise or certain genetic diseases. Muscular atrophy not only affects the patient's quality of daily life, but may also lead to serious health problems such as mobility problems and metabolic dysfunction. Currently, treatments for muscular atrophy mainly include drug therapy, physical therapy and nutritional support. However, these methods can usually only relieve symptoms and cannot fundamentally solve the damage and loss of muscle tissue function.

[0003] In recent years, stem cell therapy, as an emerging treatment method, has shown great potential in repairing damaged tissues and restoring organ function. In particular, muscle stem cells (such as satellite cells) are considered to be an ideal cell source for treating muscular atrophy due to their self-renewal and multidirectional differentiation capabilities. However, how to effectively isolate, culture, transplant and activate these muscle stem cells to achieve the best therapeutic effect remains a scientific problem that needs to be solved. Therefore, in response to the above technical problems, it is necessary to provide a muscle stem cell therapy method for treating muscular atrophy. Summary of the invention

[0004] The object of the present invention is to provide a muscle stem cell therapy method for treating muscular atrophy to solve the above-mentioned problems.

[0005] In order to achieve the above purpose, the technical solution provided by an embodiment of the present invention is as follows:

[0006] A muscle stem cell therapy method for treating muscular atrophy, comprising:

[0007] S1: Muscle stem cells are isolated from the patient's own muscle tissue or healthy donors;

[0008] S2: culturing and expanding the muscle stem cells;

[0009] S3: The cultured and expanded muscle stem cells are transplanted into the patient's damaged muscle area by injection;

[0010] S4: Activate transplanted muscle stem cells through electrical stimulation to promote their differentiation and proliferation;

[0011] S5: After transplantation and activation of stem cells, transplant patients should receive rehabilitation training and regular monitoring.

[0012] As a further improvement of the present invention, the step of isolating muscle stem cells from the patient's own or a healthy donor's muscle tissue in S1 includes using enzyme digestion and cell sorting technology, specifically including digesting the muscle tissue with collagenase or trypsin, and then performing cell sorting by flow cytometry to obtain purified muscle stem cells.

[0013] As a further improvement of the present invention, the culture and expansion of muscle stem cells in S2 under laboratory conditions includes inoculating the isolated muscle stem cells in a culture medium containing growth factors and nutrients, and culturing them in an incubator at 37°C and a carbon dioxide concentration of 5%, and regularly replacing the culture medium to promote cell proliferation.

[0014] As a further improvement of the present invention, in S3, the cultured and expanded muscle stem cells are suspended in physiological saline or culture medium and injected into multiple parts of the patient's damaged muscles through a syringe or a microneedle syringe to ensure uniform distribution of the cells.

[0015] As a further improvement of the present invention, the transplanted muscle stem cells are activated by electrical stimulation in S4, specifically including placing electrodes in the damaged muscle area after transplantation, and promoting the differentiation and proliferation of muscle stem cells by low-frequency electrical stimulation (1-10 Hz).

[0016] As a further improvement of the present invention, the transplanted muscle stem cells are activated by a drug activation method in S4, and the drugs include differentiation-promoting factors and growth factors, specifically including local or systemic injection of muscle differentiation factors and insulin-like growth factors after transplantation.

[0017] As a further improvement of the present invention, the transplanted muscle stem cells are activated by genetic engineering methods in S4, specifically including using gene editing technology such as CRISPR-Cas9 system to genetically modify muscle stem cells to enhance their differentiation and proliferation capabilities, and performing genetic modification before or after transplantation.

[0018] As a further improvement of the present invention, the rehabilitation training performed in S5 includes aerobic exercise and strength training, specifically including running, swimming and weightlifting training with gradually increasing intensity under the guidance of a professional rehabilitation therapist to promote recovery of muscle function.

[0019] As a further improvement of the present invention, the regular monitoring in S5 includes evaluating the recovery of muscle function through imaging examinations and biochemical indicators, specifically including using MRI or ultrasound to examine the structural changes and blood flow of muscle tissue, and detecting muscles through blood.

[0020] As a further improvement of the present invention, the step of culturing and amplifying muscle stem cells in S2 also includes culturing through a three-dimensional culture system, specifically including using a bioreactor and a scaffold material to simulate the in vivo microenvironment.

[0021] Compared with the prior art, the advantages of the present invention are:

[0022] This program provides a muscle stem cell therapy for the treatment of muscular atrophy. It isolates muscle stem cells from the patient's own muscle tissue or healthy donors to avoid immune rejection and provide a variety of cell sources. It uses enzyme digestion and flow cytometry sorting technology to obtain high-purity cells and improve the success rate of culture and transplantation. The cells are cultured in a culture medium containing growth factors and nutrients, and are replaced regularly to maintain activity and proliferation ability. Multi-point injection technology ensures the uniform distribution of cells in the damaged muscle and enhances the therapeutic effect. A variety of activation methods, such as electrical stimulation, drugs and genetic engineering, promote cell differentiation and proliferation. Postoperative rehabilitation training is combined with regular imaging and biochemical monitoring to systematically restore muscle function. The three-dimensional culture system simulates the in vivo microenvironment and improves cell physiological function and survival rate. This method significantly improves the muscle function and quality of life of patients with muscular atrophy through systematic steps and innovative technologies, from cell isolation, culture, transplantation, activation to postoperative rehabilitation. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 This is a schematic diagram of the muscle stem cell therapy for treating muscular atrophy according to the present invention. DETAILED DESCRIPTION

[0024] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention; it is obvious that the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments, and all other embodiments obtained by ordinary technicians in this field based on the embodiments of the present invention without making creative work are within the scope of protection of the present invention.

[0025] Example:

[0026] See also Figure 1 In order to achieve the above purpose, a technical solution provided by an embodiment of the present invention is as follows:

[0027] A muscle stem cell therapy method for treating muscular atrophy, comprising:

[0028] S1: Muscle stem cells are isolated from the patient's own muscle tissue or healthy donors;

[0029] S2: Cultivating and expanding muscle stem cells;

[0030] S3: The cultured and expanded muscle stem cells are transplanted into the patient's damaged muscle area by injection;

[0031] S4: Activate transplanted muscle stem cells through electrical stimulation to promote their differentiation and proliferation;

[0032] S5: After transplantation and activation of stem cells, transplant patients should receive rehabilitation training and regular monitoring.

[0033] Among them, this program provides a muscle stem cell therapy for the treatment of muscular atrophy. By isolating muscle stem cells from the patient's own or healthy donor's muscle tissue, immune rejection is avoided, and a variety of cell sources are provided. Enzymatic digestion and flow cytometer sorting technology are used to obtain high-purity cells to improve the success rate of culture and transplantation. The cells are cultured in a culture medium containing growth factors and nutrients, and are replaced regularly to maintain activity and proliferation ability. Multi-point injection technology ensures that cells are evenly distributed in damaged muscles and enhances the therapeutic effect. Various activation methods such as electrical stimulation, drugs and genetic engineering promote cell differentiation and proliferation. Postoperative rehabilitation training is combined with regular imaging and biochemical monitoring to systematically restore muscle function. The three-dimensional culture system simulates the in vivo microenvironment and improves cell physiological function and survival rate. This method significantly improves the muscle function and quality of life of patients with muscular atrophy through systematic steps and innovative technologies, from cell isolation, culture, transplantation, activation to postoperative rehabilitation.

[0034] The steps of isolating muscle stem cells from the patient's own or healthy donor's muscle tissue in S1 include using enzyme digestion and cell sorting technology, specifically including digesting the muscle tissue with collagenase or trypsin, and then performing cell sorting by flow cytometry to obtain purified muscle stem cells.

[0035] Among them, the purpose of isolating muscle stem cells from the patient's own muscle tissue or healthy donors is to obtain muscle stem cells, which can be used to treat muscle atrophy. Muscle stem cells can come from the patient's own (autologous cells) or healthy donors (allogeneic cells). First, the muscle tissue needs to be processed to break it down into single cells. This process is usually done by enzymatic digestion.

[0036] After enzymatic digestion, the resulting cell suspension contains various types of cells. In order to obtain purified muscle stem cells, cell sorting is required. Flow cytometry is an instrument that can sort and analyze cells based on their physical and chemical properties. The cell suspension passes through the narrow flow channel of the flow cytometer, and individual cells pass through one by one. The flow cytometer uses a laser beam to illuminate the cells and analyzes the characteristics of each cell based on the scattered light and fluorescence signals of the cells. After sorting by flow cytometry, high-purity muscle stem cells are obtained.

[0037] The culture and expansion of muscle stem cells under laboratory conditions in S2 includes inoculating the isolated muscle stem cells in a culture medium containing growth factors and nutrients, and culturing them in an incubator at 37°C and 5% carbon dioxide concentration, and regularly replacing the culture medium to promote cell proliferation.

[0038] Among them, the muscle stem cells separated from step S1 are inoculated into the culture medium, which is a liquid or gel containing nutrients that can support the growth and proliferation of cells. In order to promote the growth and proliferation of muscle stem cells, growth factors and nutrients are usually added to the culture medium. Proteins that can stimulate cell growth and differentiation, such as basic fibroblast growth factor (bFGF) and insulin-like growth factor (IGF), can also be included in the culture medium. Amino acids, glucose, vitamins, minerals, etc. provide the basic nutrients required by cells.

[0039] 37℃ is the normal body temperature of the human body and the optimal temperature for in vitro culture of muscle stem cells. The CO2 concentration in the incubator is maintained at 5%, which helps to keep the pH value of the culture medium stable. The carbon dioxide and bicarbonate system in the culture medium interact to form a buffer system to ensure that the cells grow in a stable pH environment.

[0040] In S3, the cultured and expanded muscle stem cells are suspended in physiological saline or culture medium and injected into multiple sites of the patient's damaged muscles via a syringe or microneedle injector to ensure even distribution of the cells.

[0041] Among them, the cultured and expanded muscle stem cells are transplanted into the damaged muscle area of ​​the patient. The purpose is to transplant the muscle stem cells cultured and expanded in the laboratory into the damaged muscle area of ​​the patient to promote repair and regeneration. The cultured and expanded muscle stem cells need to be suspended in a solution containing a physiological concentration (about 0.9%) of sodium chloride to maintain the stability and vitality of the cells.

[0042] Different types of injection tools can be used to accurately inject the cell suspension into the damaged muscle area of ​​the patient. Common medical devices include syringes and microneedle syringes. Choose the appropriate injection tool according to the patient's specific situation, and inject the cell suspension into multiple parts of the damaged muscle to ensure that the cells are evenly distributed. In order to fully cover the damaged area and increase the contact area between cells and muscle tissue, the cell suspension needs to be injected into multiple parts of the damaged muscle. Through multi-point injection, it is ensured that the transplanted muscle stem cells can be evenly distributed in the target area, thereby maximizing their repair and regeneration functions.

[0043] In S4, transplanted muscle stem cells are activated by electrical stimulation, which specifically includes placing electrodes on the damaged muscle area after transplantation and promoting the differentiation and proliferation of muscle stem cells through low-frequency electrical stimulation (1-10Hz).

[0044] Among them, in step S4, the transplanted muscle stem cells are activated by placing electrodes on the patient's damaged muscle area and applying low-frequency electrical stimulation (frequency of 1-10Hz). This process aims to promote the differentiation and proliferation of these stem cells through electrical stimulation, thereby enhancing their ability to repair and regenerate damaged muscle tissue.

[0045] In S4, transplanted muscle stem cells are activated by a drug activation method, and the drugs include differentiation-promoting factors and growth factors, specifically including local or systemic injection of muscle differentiation factor and insulin-like growth factor after transplantation.

[0046] Among them, in S4, transplanted muscle stem cells are activated by drug activation methods. The specific operation includes local or systemic injection of differentiation-promoting factors (such as muscle differentiation factor) and growth factors (such as insulin-like growth factor) after cell transplantation. These drugs can promote the differentiation and proliferation of muscle stem cells, thereby enhancing their ability to repair and regenerate damaged muscle tissue.

[0047] In S4, transplanted muscle stem cells are activated by genetic engineering methods, specifically including using gene editing technology such as the CRISPR-Cas9 system to genetically modify muscle stem cells to enhance their differentiation and proliferation capabilities, and performing genetic modification before or after transplantation.

[0048] Among them, in S4, transplanted muscle stem cells are activated by genetic engineering methods. The specific operation includes using gene editing technology (such as CRISPR-Cas9 system) to genetically modify muscle stem cells to enhance their differentiation and proliferation capabilities. This genetic modification can be performed before or after cell transplantation, thereby improving the function and effect of muscle stem cells and promoting the repair and regeneration of damaged muscle tissue.

[0049] The rehabilitation training conducted in S5 includes aerobic exercise and strength training, specifically running, swimming and weightlifting training with gradually increasing intensity under the guidance of professional rehabilitation therapists to promote the recovery of muscle function.

[0050] Among them, in step S5, rehabilitation training includes aerobic exercise and strength training. The specific operation is to gradually increase the intensity of running, swimming and weightlifting training under the guidance of professional rehabilitation therapists. These training methods are designed to promote the recovery of muscle function, enhance muscle strength and endurance through systematic and progressive exercise, and thus improve the overall rehabilitation effect of patients.

[0051] Regular monitoring in S5 includes evaluating the recovery of muscle function through imaging examinations and biochemical indicators, including using MRI or ultrasound to examine the structural changes and blood flow of muscle tissue, and blood testing of muscles.

[0052] Among them, regular monitoring in S5 includes evaluating the recovery of muscle function through imaging examinations and biochemical indicators. Specific operations include using MRI or ultrasound to examine the structural changes and blood flow of muscle tissue, and evaluating muscle biochemical indicators through blood tests. These monitoring methods can provide detailed muscle recovery information and help the medical team adjust the rehabilitation plan to optimize the treatment effect.

[0053] The step of culturing and expanding muscle stem cells in S2 also includes culturing through a three-dimensional culture system, specifically including the use of a bioreactor and scaffold materials to simulate the in vivo microenvironment.

[0054] Among them, the process of culturing and expanding muscle stem cells in S2 also includes culturing through a three-dimensional culture system. The specific operations include using a bioreactor and scaffold materials to simulate the in vivo microenvironment. The bioreactor provides dynamic culture conditions, while the scaffold material provides structural support and a suitable growth environment for the cells, thereby better promoting the proliferation and differentiation of muscle stem cells and improving their survival rate and function after transplantation in the body.

[0055] It will be apparent to those skilled in the art that the invention is not limited to the details of the exemplary embodiments described above and that the invention can be implemented in other specific forms without departing from the spirit or essential features of the invention. Therefore, the embodiments should be considered exemplary and non-limiting in all respects, and the scope of the invention is defined by the appended claims rather than the foregoing description, and it is intended that all variations falling within the meaning and scope of the equivalent elements of the claims be included in the invention. Any reference numeral in a claim should not be considered as limiting the claim to which it relates.

[0056] In addition, it should be understood that although the present specification is described according to embodiments, not every embodiment contains only one independent technical solution. This narrative method of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation methods that those skilled in the art can understand.

Claims

1. A muscle stem cell therapy method for treating muscular atrophy, characterized in that: include: S1: Muscle stem cells are isolated from the patient's own muscle tissue or healthy donors; S2: culturing and expanding the muscle stem cells; S3: The cultured and expanded muscle stem cells are transplanted into the patient's damaged muscle area by injection; S4: Activate transplanted muscle stem cells through electrical stimulation to promote their differentiation and proliferation; S5: After transplantation and activation of stem cells, transplant patients should receive rehabilitation training and regular monitoring.

2. A muscle stem cell therapy method for treating muscular atrophy according to claim 1, characterized in that: The step of isolating muscle stem cells from the patient's own or healthy donor's muscle tissue in S1 includes using enzyme digestion and cell sorting technology, specifically including digesting the muscle tissue with collagenase or trypsin, and then performing cell sorting by flow cytometry to obtain purified muscle stem cells.

3. A muscle stem cell therapy method for treating muscular atrophy according to claim 1, characterized in that: The culture and expansion of muscle stem cells under laboratory conditions in S2 includes inoculating the isolated muscle stem cells in a culture medium containing growth factors and nutrients, and culturing them in an incubator at 37° C. and a carbon dioxide concentration of 5%, and regularly replacing the culture medium to promote cell proliferation.

4. A muscle stem cell therapy method for treating muscular atrophy according to claim 1, characterized in that: In the S3, the cultured and expanded muscle stem cells are suspended in physiological saline or culture medium and injected into multiple sites of the patient's damaged muscles via a syringe or a microneedle syringe to ensure uniform distribution of the cells.

5. A muscle stem cell therapy method for treating muscular atrophy according to claim 1, characterized in that: In the S4, the transplanted muscle stem cells are activated by an electrical stimulation method, specifically including placing electrodes in the damaged muscle area after transplantation, and promoting the differentiation and proliferation of muscle stem cells by low-frequency electrical stimulation (1-10 Hz).

6. A muscle stem cell therapy method for treating muscular atrophy according to claim 1, characterized in that: In S4, the transplanted muscle stem cells are activated by a drug activation method, wherein the drugs include differentiation-promoting factors and growth factors, specifically including local or systemic injection of muscle differentiation factors and insulin-like growth factors after transplantation.

7. A muscle stem cell therapy method for treating muscular atrophy according to claim 1, characterized in that: In S4, transplanted muscle stem cells are activated by genetic engineering methods, specifically including using gene editing technology such as the CRISPR-Cas9 system to genetically modify muscle stem cells to enhance their differentiation and proliferation capabilities, and performing genetic modification before or after transplantation.

8. A muscle stem cell therapy method for treating muscular atrophy according to claim 1, characterized in that: The rehabilitation training performed in S5 includes aerobic exercise and strength training, specifically including running, swimming and weightlifting training with gradually increasing intensity under the guidance of a professional rehabilitation therapist to promote the recovery of muscle function.

9. A muscle stem cell therapy method for treating muscular atrophy according to claim 1, characterized in that: The regular monitoring in S5 includes evaluating the recovery of muscle function through imaging examinations and biochemical indicators, specifically including using MRI or ultrasound to examine the structural changes and blood flow of muscle tissue, and testing muscles through blood.

10. A muscle stem cell therapy method for treating muscle atrophy according to claim 1, characterized in that: The step of culturing and expanding muscle stem cells in S2 also includes culturing through a three-dimensional culture system, specifically including the use of a bioreactor and a scaffold material to simulate the in vivo microenvironment.

Citation Information

Cited By

  • Smooth muscle stem cell treatment optimization method and system for female pelvic floor dysfunction

    CN120285015A